The arrival of Mpox in Venezuela: Why so few cases?

• Mario Comegna,
• David M. Flora-Noda,
• Fhabián S. Carrión-Nessi,
• Ioannis Adamidis,
• Julio Moreno,
• María E. Landaeta,
• David A. Forero-Peña

Affiliations

Mario Comegna

“José María Vargas” School of Medicine, Central University of Venezuela, Caracas, Venezuela; Infectious Diseases Department, Vargas Hospital of Caracas, Caracas, Venezuela

David M. Flora-Noda

“Luis Razetti” School of Medicine, Central University of Venezuela, Caracas, Venezuela; Infectious Diseases Department, University Hospital of Caracas, Caracas, Venezuela

Fhabián S. Carrión-Nessi

“Luis Razetti” School of Medicine, Central University of Venezuela, Caracas, Venezuela; Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela

Ioannis Adamidis

Infectious Diseases Department, Vargas Hospital of Caracas, Caracas, Venezuela

Julio Moreno

Infectious Diseases Department, Vargas Hospital of Caracas, Caracas, Venezuela

María E. Landaeta

“Luis Razetti” School of Medicine, Central University of Venezuela, Caracas, Venezuela; Infectious Diseases Department, University Hospital of Caracas, Caracas, Venezuela

David A. Forero-Peña

Corresponding author.; “Luis Razetti” School of Medicine, Central University of Venezuela, Caracas, Venezuela; Infectious Diseases Department, University Hospital of Caracas, Caracas, Venezuela; Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela